However, further experiments will be needed to demonstrate demethylation of SFRP2 in primary and metastatic cancer tissues and to confirm elevated SFRP2 serum levels to detect the type and location of the early bone metastasis of prostate cancers. Here, SFRP2 is linked to metastatic malignant neoplasm.